Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

NCT00862355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Carcinoma

Interventions

DRUG: SPARC147609
DRUG: Reference147609

Sponsor

Sun Pharma Advanced Research Company Limited